Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
Article has an altmetric score of 42

See more details

Posted by 68 X users
Referenced in 3 patents
176 readers on Mendeley
  • Article usage
  • Citations to this article (68)
Advertisement

Resource and Technical AdvanceIn-Press PreviewCOVID-19Virology Free access | 10.1172/jci.insight.139042

Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens

Jun Liu,1 April M. Babka,1 Brian J. Kearney,2 Sheli R. Radoshitzky,3 Jens H. Kuhn,4 and Xiankun Zeng1

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Liu, J. in: PubMed | Google Scholar

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Babka, A. in: PubMed | Google Scholar

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Kearney, B. in: PubMed | Google Scholar

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Radoshitzky, S. in: PubMed | Google Scholar |

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Kuhn, J. in: PubMed | Google Scholar |

1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America

4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America

Find articles by Zeng, X. in: PubMed | Google Scholar

Published May 7, 2020 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.139042.
Copyright © 2020, American Society for Clinical Investigation
Published May 7, 2020 - Version history
View PDF
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China in December 2019. The virus rapidly spread globally, resulting in a public-health crisis including more than 3.1 million cases and 224,000 deaths as of May 1, 2020. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected formalin fixed paraffin embedded (FFPE) cell pellets. We identified a suitable rabbit polyclonal anti-SARS-CoV spike protein antibody and a mouse monoclonal anti-SARS-CoV nucleocapsid protein (NP) antibody for cross detection of the respective SARS-CoV-2 proteins by immunohistochemistry (IHC) and immunofluorescence assay (IFA). Next, we established RNAscope in situ hybridization (ISH) to detect SARS-CoV-2 RNA. Furthermore, we established a multiplex fluorescence ISH (mFISH) to detect positive-sense SARS-CoV-2 RNA and negative-sense SARS-CoV-2 RNA (a replicative intermediate indicating viral replication). Finally, we developed a dual staining assay using IHC and ISH to detect SARS-CoV-2 antigen and RNA in the same FFPE section. These reagents and assays will accelerate COVID-19 pathogenesis studies in humans and in COVID-19 animal models.

Supplemental material

View Supplemental Table 1 and 2

Version history
  • Version 1 (May 7, 2020): In-Press Preview
  • Version 2 (June 18, 2020): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 42
  • Article usage
  • Citations to this article (68)

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts

Posted by 68 X users
Referenced in 3 patents
176 readers on Mendeley
See more details